Deutsche Bank’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-2,680
| Closed | -$169K | – | 4503 |
|
|
2021
Q2 | $169K | Buy |
2,680
+1,368
| +104% | +$86.3K | ﹤0.01% | 3826 |
|
|
2021
Q1 | $162K | Sell |
1,312
-123
| -9% | -$15.2K | ﹤0.01% | 3705 |
|
|
2020
Q4 | $163K | Buy |
1,435
+420
| +41% | +$47.7K | ﹤0.01% | 3516 |
|
|
2020
Q3 | $121K | Buy |
1,015
+330
| +48% | +$39.3K | ﹤0.01% | 3414 |
|
|
2020
Q2 | $86K | Buy |
685
+267
| +64% | +$33.5K | ﹤0.01% | 3472 |
|
|
2020
Q1 | $81K | Buy |
418
+23
| +6% | +$4.46K | ﹤0.01% | 3281 |
|
|
2019
Q4 | $131K | Sell |
395
-12
| -3% | -$3.98K | ﹤0.01% | 3391 |
|
|
2019
Q3 | $130K | Sell |
407
-249
| -38% | -$79.5K | ﹤0.01% | 3352 |
|
|
2019
Q2 | $282K | Buy |
656
+466
| +245% | +$200K | ﹤0.01% | 3577 |
|
|
2019
Q1 | $106K | Sell |
190
-222
| -54% | -$124K | ﹤0.01% | 4143 |
|
|
2018
Q4 | $121K | Sell |
412
-146
| -26% | -$42.9K | ﹤0.01% | 3997 |
|
|
2018
Q3 | $396K | Buy |
558
+361
| +183% | +$256K | ﹤0.01% | 3847 |
|
|
2018
Q2 | $115K | Buy |
197
+82
| +71% | +$47.9K | ﹤0.01% | 4328 |
|
|
2018
Q1 | $310K | Buy |
+115
| New | +$310K | ﹤0.01% | 3878 |
|